(Total Views: 469)
Posted On: 10/05/2020 12:00:50 PM
Post# of 35

$ARCT News Article - Arcturus Therapeutics Announces Completion of First Three Dose Escalation Cohorts in Phase 1 Study of ARCT-810, Therapeutic Candidate for Ornithine Transcarbamylase (OTC) Deficiency https://marketwirenews.com/news-releases/arct...83139.html


My Twitter: WhyteStocks